中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2015年
43期
6977-6982
,共6页
张德盛%刘树平%刘跃洪%周宇%陈曦
張德盛%劉樹平%劉躍洪%週宇%陳晞
장덕성%류수평%류약홍%주우%진희
生物材料%纳米材料%羟基磷灰石%植入材料%脊柱融合%椎体高度%组织构建
生物材料%納米材料%羥基燐灰石%植入材料%脊柱融閤%椎體高度%組織構建
생물재료%납미재료%간기린회석%식입재료%척주융합%추체고도%조직구건
背景:纳米羟基磷灰石/聚酰胺66复合物在力学属性方面和人体皮质骨十分接近,且具有成骨活性,是一种安全可靠的骨材料。目的:探讨纳米羟基磷灰石/聚酰胺66复合生物活性支撑材料在恢复椎体结构和高度中的作用。方法:纳入177例脊柱疾病患者,其中男116例,女61例,年龄17-81岁,包括97例脊柱骨折、5例脊柱原发性肿瘤、17例脊柱结核及58例颈椎病,均实施前路减压纳米羟基磷灰石/聚酰胺66复合生物活性支撑体植骨融合内固定治疗。治疗后随访36个月,进行影像学分析、Frankel脊髓损伤分级、植骨融合、目测类比评分、JOA及SF-36评分评估。结果与结论:经随访,除1例颈椎骨折患者在术后出现轻微支撑体移位之外,其余患者均未出现支撑体脱出或破裂现象,植骨融合率为96.0%,平均支撑体下沉距离为1.7 mm;与治疗前比较,脊柱骨折97例患者治疗后的神经功能得到有不同程度改善(P <0.05);177例患者的目测类比评分、JOA评分及SF-36评分较治疗前显著改善(P <0.05)。表明在脊柱重建过程中使用纳米羟基磷灰石/聚酰胺66复合生物活性支撑材料可提高植骨融合率,有效恢复椎体结构和高度。
揹景:納米羥基燐灰石/聚酰胺66複閤物在力學屬性方麵和人體皮質骨十分接近,且具有成骨活性,是一種安全可靠的骨材料。目的:探討納米羥基燐灰石/聚酰胺66複閤生物活性支撐材料在恢複椎體結構和高度中的作用。方法:納入177例脊柱疾病患者,其中男116例,女61例,年齡17-81歲,包括97例脊柱骨摺、5例脊柱原髮性腫瘤、17例脊柱結覈及58例頸椎病,均實施前路減壓納米羥基燐灰石/聚酰胺66複閤生物活性支撐體植骨融閤內固定治療。治療後隨訪36箇月,進行影像學分析、Frankel脊髓損傷分級、植骨融閤、目測類比評分、JOA及SF-36評分評估。結果與結論:經隨訪,除1例頸椎骨摺患者在術後齣現輕微支撐體移位之外,其餘患者均未齣現支撐體脫齣或破裂現象,植骨融閤率為96.0%,平均支撐體下沉距離為1.7 mm;與治療前比較,脊柱骨摺97例患者治療後的神經功能得到有不同程度改善(P <0.05);177例患者的目測類比評分、JOA評分及SF-36評分較治療前顯著改善(P <0.05)。錶明在脊柱重建過程中使用納米羥基燐灰石/聚酰胺66複閤生物活性支撐材料可提高植骨融閤率,有效恢複椎體結構和高度。
배경:납미간기린회석/취선알66복합물재역학속성방면화인체피질골십분접근,차구유성골활성,시일충안전가고적골재료。목적:탐토납미간기린회석/취선알66복합생물활성지탱재료재회복추체결구화고도중적작용。방법:납입177례척주질병환자,기중남116례,녀61례,년령17-81세,포괄97례척주골절、5례척주원발성종류、17례척주결핵급58례경추병,균실시전로감압납미간기린회석/취선알66복합생물활성지탱체식골융합내고정치료。치료후수방36개월,진행영상학분석、Frankel척수손상분급、식골융합、목측류비평분、JOA급SF-36평분평고。결과여결론:경수방,제1례경추골절환자재술후출현경미지탱체이위지외,기여환자균미출현지탱체탈출혹파렬현상,식골융합솔위96.0%,평균지탱체하침거리위1.7 mm;여치료전비교,척주골절97례환자치료후적신경공능득도유불동정도개선(P <0.05);177례환자적목측류비평분、JOA평분급SF-36평분교치료전현저개선(P <0.05)。표명재척주중건과정중사용납미간기린회석/취선알66복합생물활성지탱재료가제고식골융합솔,유효회복추체결구화고도。
BACKGROUND:Nanohydroxyapatite/polyamide 66 composite is very close to the human cortical bone in terms of mechanical properties, and has osteogenic activity, which is a safe and reliable bone material. OBJECTIVE:To investigate the effect of nanohydroxyapatite/polyamide 66 composite bioactive supporting material on the restoration of vertebral structure and height. METHODS: Totaly 177 patients with spinal diseases, 116 males and 61 females, aged 17-81 years, were enroled, including 97 cases of spinal fractures, 5 cases of primary tumors of the spine, 17 cases of spinal tuberculosis and 58 cases of cervical spondylosis. The nanohydroxyapatite/polyamide 66 composite bioactive supporting body was filed into the bone grafts of patients and then subjected to anterior decompression and internal fixation. After 36 months of folow-up, imaging analysis, Frankel spinal cord injury classification, bone graft fusion, visual analog scale scores,Short Form 36 and Japanese Orthopedic Association scores were evaluated. RESULTS AND CONCLUSION:During the folow-up, except one patient with cervical spine fracture appeared to have slight supporting body displacement, there was no supporting body prolapse or rupture phenomena. The bone graft fusion rate was 96.0%, the average supporting body sinking distance was 1.7 mm. After treatment, 97 patients with spinal fractures had different degree of improvement in the neurological function (P < 0.05); the visual analog scale scores, Short Form 36 and Japanese Orthopedic Association scores were improved significantly in al the 177 patients compared with before treatment (P < 0.05). These results demonstrate that the use of nanohydroxyapatite/polyamide 66 composite bioactive supporting material for spinal reconstruction can improve the bone fusion rate, and restore the vertebral structure and height effectively.